Mid-regional-pro-adrenomedullin plasma levels are increased in obese adolescents

Purpose Recently, adrenomedullin (ADM) was defined as a new member of the adipokine family. ADM secreted by adipocytes, through its vasodilator and antioxidant actions, might be protective against metabolic syndrome-associated cardiovascular complications. The aim of the study was to assess plasma m...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nutrition Vol. 55; no. 3; pp. 1255 - 1260
Main Authors Del Ry, Silvia, Cabiati, Manuela, Bianchi, Vanessa, Caponi, Laura, Di Cecco, Pietro, Marchi, Benedetta, Randazzo, Emioli, Caselli, Chiara, Prescimone, Tommaso, Clerico, Aldo, Federico, Giovanni
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2016
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1436-6207
1436-6215
1436-6215
DOI10.1007/s00394-015-0938-6

Cover

More Information
Summary:Purpose Recently, adrenomedullin (ADM) was defined as a new member of the adipokine family. ADM secreted by adipocytes, through its vasodilator and antioxidant actions, might be protective against metabolic syndrome-associated cardiovascular complications. The aim of the study was to assess plasma mid-regional (MR)-proADM levels in obese adolescents compared to normal-weight subjects and its relation with BMI, body composition and metabolic indices. Methods Plasma MR-proADM was measured in 32 healthy adolescents [BMI z -score (mean ± SEM) = 0.6 ± 0.09 and 0.8 ± 0.07 in females and males, respectively] and in 51 age-matched obese adolescents [BMI z -score (mean ± SEM) = 2.8 ± 0.12 and 2.9 ± 0.08 in female and males, respectively] by a time-resolved amplified cryptate emission technology assay. Results Plasma MR-proADM levels resulted significantly higher in obese than in normal-weight adolescents (MR-proADM: 0.33 ± 0.1 vs 0.40 ± 0.1 nmol/L, p  < 0.0001). Using univariate analysis, we observed that MR-proADM correlated significantly with BMI z -score ( p  < 0.0001), fat mass ( p  < 0.0001), circulating insulin ( p  < 0.004), HOMA-IR ( p  < 0.005), total cholesterol ( p  < 0.03) and LDL-cholesterol ( p  < 0.05). Including MR-proADM as response variable and its significant correlates into a multiple regression analysis, we observed that fat mass ( p  = 0.014) and BMI z -score ( p  = 0.036) were independent determinants of circulating MR-proADM. Conclusions Our study shows for the first time that obese adolescents have higher circulating levels of MR-proADM compared with normal-weight, appropriate controls suggesting its important involvement in obese patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1436-6207
1436-6215
1436-6215
DOI:10.1007/s00394-015-0938-6